Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation

Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation

OBJECTIVES:. Bivalirudin, an IV direct thrombin inhibitor, and unfractionated heparin (UFH) are frequently used anticoagulants in the pediatric critical care setting. An accurate, specific, point-of-care test to quantify and detect anticoagulation resistance is not currently available. This study ev...

Full description

Bibliographic Details
Main Authors: Galit H. Frydman, DVM, ScD, Barry M. Berger, MD, FCAP, Vadim Kostousov, MD, Karen Bruzdovski, BS, Dimitrios P. Papageorgiou, PhD, Amir Navaei, MD, Shiu-Ki Rocky Hui, MD, Jun Teruya, MD, DSc
Format: Article
Language:English
Published: Wolters Kluwer 2022-10-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000776

Internet

http://journals.lww.com/10.1097/CCE.0000000000000776

Similar Items